HopeStage
Back to all studies
Recruitment unclearEUCTR 2011-004692-36

COMBIVAR. Randomized double-blind trial of two parallel groups design to evaluate the efficacy of smoking cessation with combined (varenicline plus nicotine patches) versus monotherapy (varenicline)

This historical record does not confirm current site availability.

Historical research recordSpainAddiction
The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Spain
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Recruitment unclear
Enrollment listed in the registry
0
Sponsor
HOSPITAL UNIVERSITARI DE BELLVITGE
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Spain
Age range
Not clearly listed
Official registry ID
EUCTR 2011-004692-36
Official title
Show the full official title

COMBIVAR. Randomized double-blind trial of two parallel groups design to evaluate the efficacy of smoking cessation with combined (varenicline plus nicotine patches) versus monotherapy (varenicline)

Recruitment & locations

Status unknown

Spain

Registry details
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is HOSPITAL UNIVERSITARI DE BELLVITGE, a hospital or academic medical center.

Want to explore more studies?

Explore studies